Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study

<div>Effects of individual studies on pooled hazard ratios (HRs) for PRDX1 and survival in solid tumors. (a) Result of sensitivity analysis for pooled OS estimation. (b) Result of sensitivity analysis for pooled DFS estimation.</div>

Disease Markers

fig4

Figure 4

Figure 4: Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study 